JP2010509937A5 - - Google Patents

Download PDF

Info

Publication number
JP2010509937A5
JP2010509937A5 JP2009538451A JP2009538451A JP2010509937A5 JP 2010509937 A5 JP2010509937 A5 JP 2010509937A5 JP 2009538451 A JP2009538451 A JP 2009538451A JP 2009538451 A JP2009538451 A JP 2009538451A JP 2010509937 A5 JP2010509937 A5 JP 2010509937A5
Authority
JP
Japan
Prior art keywords
monoclonal antibody
antigen
variable region
cell line
binding fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2009538451A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010509937A (ja
Filing date
Publication date
Priority claimed from US11/562,759 external-priority patent/US7488807B2/en
Application filed filed Critical
Publication of JP2010509937A publication Critical patent/JP2010509937A/ja
Publication of JP2010509937A5 publication Critical patent/JP2010509937A5/ja
Withdrawn legal-status Critical Current

Links

JP2009538451A 2006-11-22 2007-11-15 プロテインa選択性を有する抗体 Withdrawn JP2010509937A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/562,759 US7488807B2 (en) 2006-11-22 2006-11-22 Antibody with protein A selectivity
PCT/US2007/084736 WO2008140570A2 (en) 2006-11-22 2007-11-15 Antibody with protein a selectivity

Publications (2)

Publication Number Publication Date
JP2010509937A JP2010509937A (ja) 2010-04-02
JP2010509937A5 true JP2010509937A5 (OSRAM) 2011-01-06

Family

ID=39417386

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009538451A Withdrawn JP2010509937A (ja) 2006-11-22 2007-11-15 プロテインa選択性を有する抗体

Country Status (4)

Country Link
US (2) US7488807B2 (OSRAM)
EP (1) EP2087003A2 (OSRAM)
JP (1) JP2010509937A (OSRAM)
WO (1) WO2008140570A2 (OSRAM)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010510524A (ja) 2006-11-22 2010-04-02 スリーエム イノベイティブ プロパティズ カンパニー 試料を調製及び分析するシステム並びに方法
US20100062418A1 (en) * 2006-11-22 2010-03-11 Mach Patrick A Inactivated and dried biological preparations
EP2137533A2 (en) * 2007-04-19 2009-12-30 3M Innovative Properties Company Uses of water-dispersible silica nanoparticles for attaching biomolecules
US8597959B2 (en) * 2007-04-19 2013-12-03 3M Innovative Properties Company Methods of use of solid support material for binding biomolecules
CN101918842A (zh) * 2007-11-20 2010-12-15 3M创新有限公司 利用含二乙炔的聚合物传感器分析细菌样品的方法
HUE026855T2 (en) 2009-04-03 2016-07-28 Univ Chicago Compositions and methods related to protein a (spa) variants
SG186290A1 (en) 2010-07-02 2013-01-30 Univ Chicago Compositions and methods related to protein a (spa) variants
BR112014003315A2 (pt) * 2011-08-15 2017-03-01 Univ Chicago composições e métodos relacionados a anticorpos para a proteína a estafilocócica
US9988439B2 (en) 2011-12-23 2018-06-05 Nicholas B. Lydon Immunoglobulins and variants directed against pathogenic microbes
EP2793944B1 (en) 2011-12-23 2025-10-08 Nicholas B. Lydon Immunoglobulins and variants directed against pathogenic microbes
ES2894867T3 (es) 2014-06-03 2022-02-16 Xbiotech Inc Composiciones y procedimientos de tratamiento y prevención de infecciones por estafilococo áureo
CN112867732A (zh) * 2018-11-21 2021-05-28 瑞泽恩制药公司 抗葡萄球菌抗体和其用途

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4741900A (en) 1982-11-16 1988-05-03 Cytogen Corporation Antibody-metal ion complexes
GB8426463D0 (en) 1984-10-19 1984-11-28 Technology Licence Co Ltd Monoclonal antibodies
JPS63273495A (ja) 1987-04-30 1988-11-10 Sekisui Chem Co Ltd 抗プロテインa単クロ−ン性抗体とその製法,および該抗体を用いるプロテインaの測定方法
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
AU4308689A (en) 1988-09-02 1990-04-02 Protein Engineering Corporation Generation and selection of recombinant varied binding proteins
US5427908A (en) 1990-05-01 1995-06-27 Affymax Technologies N.V. Recombinant library screening methods
ES2139598T3 (es) 1990-07-10 2000-02-16 Medical Res Council Procedimientos para la produccion de miembros de parejas de union especifica.
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
WO1992009690A2 (en) 1990-12-03 1992-06-11 Genentech, Inc. Enrichment method for variant proteins with altered binding properties
ES2330052T3 (es) 1991-03-01 2009-12-03 Dyax Corporation Proteina quimerica que comprende micro-proteinas que tienen dos o mas puentes disulfuro y relaizaciones de las mismas.
ATE414768T1 (de) 1991-04-10 2008-12-15 Scripps Research Inst Bibliotheken heterodimerer rezeptoren mittels phagemiden
DE4122599C2 (de) 1991-07-08 1993-11-11 Deutsches Krebsforsch Phagemid zum Screenen von Antikörpern
US6994855B1 (en) 1994-08-22 2006-02-07 The Provost Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin S. aureus fibrinogen binding protein gene
US6008341A (en) 1994-08-22 1999-12-28 The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin S. aureus fibrinogen binding protein gene
US5594116A (en) 1995-11-08 1997-01-14 Promega Corporation Tryptase polyclonal antibody and purification method for use in human tryptase immunoassay
FR2746398B1 (fr) 1996-03-21 1998-04-30 Bio Merieux Anticorps specifique de staphylococcus aureaus, et utilisations
EP2339344A1 (en) 2001-06-15 2011-06-29 Inhibitex, Inc. Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus
JP4363986B2 (ja) 2001-12-21 2009-11-11 イミュネックス・コーポレーション タンパク質の精製方法
WO2004048975A1 (ja) * 2002-11-22 2004-06-10 Daiichi Pure Chemicals Co., Ltd. 黄色ブドウ球菌の検査方法
EP2095123A2 (en) * 2006-11-22 2009-09-02 3M Innovative Properties Company Fluidic antibody-containing devices and methods

Similar Documents

Publication Publication Date Title
JP2010509937A5 (OSRAM)
JP2010513228A5 (OSRAM)
HRP20201634T1 (hr) Monoklonsko protutijelo protiv interleukina-31
CA2953714C (en) Anti-tnfa antibodies with ph-dependent antigen binding
JP2013198490A5 (OSRAM)
PE20110801A1 (es) Anticuerpos con reactividad cruzada y biespecificos anti-il-17a/f
NZ595464A (en) Alpha-4-beta-7 heterodimer specific antagonist antibody
NZ597023A (en) Monoclonal antibodies that bind to hGM-CSF and medical compositions comprising same
WO2013037484A8 (en) ANTI-αβTCR ANTIBODY
JP2015028021A5 (OSRAM)
FI3683235T3 (fi) Anti-IL-33-vasta-aineita ja niiden käyttöjä
NO20074867L (no) Antistoffer mot CCR5 og anvendelser derav
EA201190132A1 (ru) Гуманизированные антитела, связывающиеся с cd19, и их применение
ES2572231T3 (es) Anticuerpos monoclonales anti-IL-21 humana
RU2017128882A (ru) Антитела к биотину и способы их применения
EA201990673A1 (ru) Антитела, специфически связывающиеся с il-17a, и их функциональные фрагменты
RU2014100111A (ru) МОЛЕКУЛЫ, СВЯЗЫВАЮЩИЕСЯ С Psl Pseudomonas, И ПУТИ ИХ ПРИМЕНЕНИЯ
HRP20140266T1 (hr) Postupci inhibiranja vezanja endosijalina na ligande
WO2008143697A3 (en) Antibody with protein a selectivity
WO2008140570A3 (en) Antibody with protein a selectivity
JP2018507254A5 (OSRAM)
MX2016004928A (es) Secuencias de anticuerpos con reaccion cruzada para staphylococcus aureus.
JP2017518260A5 (OSRAM)
RU2015121617A (ru) Способы лечения заболеваний, ассоциированных с s. aureus
JP2011509650A5 (OSRAM)